Biocan novel PI/L4, Lyophilisate and solvent for suspension for injection for dogs
Canine live vaccine against parainfluenza and inactivated vaccine against four serovars of leptospirosis. Active immunization of dogs from 6 weeks of age.
Composition per 1 ml dose:
Lyophilisate (live attenuated):
Canine Parainfluenza Type 2 virus, strain CPiV-2 Bio 15 103.1 TCID50* - 105.1 TCID50*
Solvent (inactivated):
Leptospira interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain MSLB 1089 GMT**≥1:51 ALR***
Leptospira interrogans serogroup canicola serovar canicola, strain MSLB 1090 GMT**≥1:51 ALR***
Leptospira kirschneri serogroup grippotyphosa serovar grippotyphosa, strain MSLB 1091 GMT**≥1:40 ALR***
Leptospira interrogans serogroup australis serovar bratislava, strain MSLB 1088 GMT**≥1:51 ALR***
Adjuvant: aluminium hydroxide (quantifies as Al2O3) 1.8-2.2 mg
* Tissue culture infectious dose – 50%
** Geometric mean titre
*** Antibody micro agglutination-lytic reaction (serology in rabbits)
Pharmaceutical form:
Lyophilisate and solvent for suspension for injection.
Lyophilisate: Spongy matter, white colour.
Solvent: Whitish liquid with easily shakeable sediments.
Indications for use, specifying the target species:
Active immunization of dogs from 6 weeks of age.
- to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus
- to prevent clinical signs, infection and urinary excretion caused by L.interrogans serogroup australis serovar bratislava
- to prevent clinical signs and urinary excretion and reduce infection caused by L.interrogans serogroup canicola serovar canicola and L. interrogans serogroup icterhaemorhagiae serovar icterohaemorrhagiae
- to prevent clinical signs and reduce infection and urinary excretion caused by L.kirschneri serogroup grippotyphosa serovar grippotyphosa
Onset of immunity:
- 3 weeks after completion of the primary course for CPiV and
- 4 weeks after completion of the primary course for Leptospira components.
Duration of immunity:
At least one year following the primary vaccination course for all components of Biocan Novel Pi/L4.
Target species
Dog
Bioveta